Renal Replacement Therapy for Undocumented Immigrants: Current Models with Medical, Financial, and Physician Perspectives-a Narrative Review

被引:13
|
作者
Douthit, Nathan T. [1 ]
Old, Christopher [1 ]
机构
[1] Brookwood Baptist Hlth Med Educ, Birmingham, AL 35211 USA
关键词
health policy; immigrants; underserved populations; renal disease; disparities; KIDNEY-TRANSPLANTATION; EMERGENT DIALYSIS; ESRD; CARE; ASSOCIATION; SERVICES; OUTCOMES; IMPACT; POLICY;
D O I
10.1007/s11606-019-05237-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Renal replacement therapy is guaranteed for all US citizens with end-stage renal disease (ESRD). Undocumented immigrants with ESRD are a particularly vulnerable subset of renal failure patients. There is no federal legislation for these patients except for the requirement to treat them during "emergency medical conditions" and federal legislation excluding them from the guarantee of renal replacement therapy described above. Different states have developed different methods for dealing with this problem, with variation in management even addressed on a center by center basis. This review of the original studies published in the literature reveals the medical, ethical, and financial problems with this situation. These patients frequently have delayed presentation to care, poor access to routine care, increased complications, increased utilization of services, and increased morbidity and mortality in an emergent dialysis model compared to chronic outpatient care. They present an ethical dilemma for practitioners who know they are providing substandard care and occasionally making decisions on how to allocate resources. Emergent dialysis is associated with inadequate reimbursement, increased threat to sustained unemployment, and an overburdening of our healthcare infrastructure. This practice puts patients at risk, places an unfair ethical burden on providers and is financially unsustainable. Special considerations described for kidney transplant and peritoneal dialysis are considered and considerations for a new model are reviewed in the paper. Ultimately accommodations must be made with the input of government, healthcare practitioners, and facilities needs to be reached to protect these vulnerable patients.
引用
收藏
页码:2246 / 2253
页数:8
相关论文
共 35 条
  • [31] A systematic review of antibiotic dosing regimens for septic patients receiving continuous renal replacement therapy: do current studies supply sufficient data?
    Li, A. M. M. Y.
    Gomersall, C. D.
    Choi, G.
    Tian, Q.
    Joynt, G. M.
    Lipman, J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (05) : 929 - 937
  • [32] Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives
    Sawami, Kosuke
    Tanaka, Atsushi
    Node, Koichi
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [33] Unlocking the Mysteries, Bridging the Gap, and Unveiling the Multifaceted Potential of Stem Cell Therapy for Cardiac Tissue Regeneration: A Narrative Review of Current Literature, Ethical Challenges, and Future Perspectives
    Abubakar, Muhammad
    Masood, Muhammad Faiq
    Javed, Izzah
    Adil, Hira
    Faraz, Muhammad Ahmad
    Bhat, Rakshita Ramesh
    Fatima, Mahek
    Abdelkhalek, Ahmad M.
    Buccilli, Barbara
    Raza, Saud
    Hajjaj, Mohsin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [34] Quality of life assessed with the medical outcomes study short form 36-item health survey of patients on renal replacement therapy: A systematic review and meta-analysis
    Liem, Ylian S.
    Bosch, Johanna L.
    Arends, Lidia R.
    Heijenbrok-Kal, Majanka H.
    Hunink, M. G. Myriam
    VALUE IN HEALTH, 2007, 10 (05) : 390 - 397
  • [35] Non-medical barriers reported by nephrologists when providing renal replacement therapy or comprehensive conservative management to end-stage kidney disease patients: a systematic review
    de Jong, Rianne W.
    Stel, Vianda S.
    Heaf, James G.
    Murphy, Mark
    Massy, Ziad A.
    Jager, Kitty J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (05) : 848 - 862